Reckitt Sets Pricing for Mead Johnson Tender Offer on 2044 Notes
The UK consumer health giant has announced pricing terms for its subsidiary's previously disclosed cash tender offer and consent solicitation.
Reckitt Advances Debt Restructuring
Reckitt Benckiser Group plc announced Thursday that its wholly-owned subsidiary Mead Johnson Nutrition Company has set pricing terms for a previously disclosed cash tender offer targeting notes due in 2044. The consumer health conglomerate, which trades on the London Stock Exchange under the ticker RKT, is proceeding with the "any and all" tender offer alongside a consent solicitation.
The Slough-based company, with a market capitalisation of approximately $45 billion, acquired Mead Johnson Nutrition in 2017 for $16.6 billion, adding the infant formula business to its portfolio of consumer health and hygiene brands. The current tender offer represents a continuation of Reckitt's ongoing capital structure management following that transformative acquisition.
Strategic Debt Management
The tender offer allows Reckitt to potentially retire long-dated debt obligations from the Mead Johnson acquisition, which could provide greater financial flexibility as the company navigates evolving market conditions. The move comes as central banks globally continue to adjust monetary policy, with the Federal Reserve's next rate decision scheduled for September 16, according to MarginX data.
Recent Corporate Activity
MarginX data shows Reckitt has been actively repurchasing its own shares in recent weeks, with buybacks of 190,000, 195,000, and 93,264 shares recorded. Share buyback programmes typically signal management confidence in the company's valuation and future prospects, while also returning capital to shareholders.
Looking Ahead
Investors will have opportunities to assess Reckitt's operational performance in the coming months. The company is scheduled to release its Q3 2026 sales and trading statement on October 21, with a results call planned for the same day. Full Q3 results are expected to follow on October 23, according to MarginX data.
Reckitt's last closing price stood at £52.72, as the company continues to manage its portfolio of brands including Lysol, Dettol, Enfamil, and Durex across health, hygiene, and nutrition categories.
This article was generated by MarginX from public news on 2026-08-13. It is not investment advice.